v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Revenue $ 3 $ 26 $ 27 $ 60
Cost of revenue 1 26 23 50
Gross profit 2   4 10
Other operating income 257 277 695 855
Operating expenses        
Research and development 1,568 1,346 4,104 4,150
Selling, general and administrative 1,268 1,392 4,025 4,002
Loss on foreign currency transactions 118   186  
Total operating expenses 2,954 2,738 8,315 8,152
Loss from operations (2,695) (2,461) (7,616) (7,287)
Non-operating income/(expense)        
Gain/(loss) on foreign currency transactions (787) (1,493) 248 (3,131)
Transaction costs allocable to warrants     (198)  
Change in fair value of the warrant liability, net 458   461  
Interest income 2 1 8 3
Total non-operating income/(expense) (327) (1,492) 519 (3,128)
Loss before income taxes (3,022) (3,953) (7,097) (10,415)
Net loss (3,022) (3,953) (7,097) (10,415)
Other comprehensive loss:        
Foreign currency translation 850 1,117 (123) 1,995
Total comprehensive loss $ (2,172) $ (2,836) $ (7,220) $ (8,420)
Basic net loss per common share $ (1.78) $ (4.75) $ (5.82) $ (12.61)
Diluted net loss per common share $ (1.78) $ (4.75) $ (5.82) $ (12.61)
Basic weighted average shares outstanding 1,701,166 831,981 1,219,450 826,193
Diluted weighted average shares outstanding 1,701,166 831,981 1,219,450 826,193

Source